Crossmark Global Holdings Inc. Sells 8,008 Shares of McKesson Corporation $MCK

Crossmark Global Holdings Inc. reduced its position in McKesson Corporation (NYSE:MCK - Free Report) by 32.9% during the 3rd quarter, according to its most recent filing with the SEC. The firm owned 16,330 shares of the company's stock after selling 8,008 shares during the quarter. Crossmark Global Holdings Inc.'s holdings in McKesson were worth $13,943,000 as of its most recent filing with the SEC.

Other large investors also recently bought and sold shares of the company. Rosenberg Matthew Hamilton boosted its holdings in shares of McKesson by 2.8% in the third quarter. Rosenberg Matthew Hamilton now owns 406 shares of the company's stock valued at $347,000 after acquiring an additional 11 shares in the last quarter. Avail Investment Partners LLC increased its stake in shares of McKesson by 1.7% during the third quarter. Avail Investment Partners LLC now owns 662 shares of the company's stock worth $566,000 after acquiring an additional 11 shares during the period. Commonwealth Financial Services LLC increased its stake in shares of McKesson by 3.8% during the third quarter. Commonwealth Financial Services LLC now owns 304 shares of the company's stock worth $260,000 after acquiring an additional 11 shares during the period. SJS Investment Consulting Inc. raised its holdings in McKesson by 7.5% during the first quarter. SJS Investment Consulting Inc. now owns 172 shares of the company's stock worth $149,000 after purchasing an additional 12 shares in the last quarter. Finally, SMART Wealth LLC raised its holdings in McKesson by 3.4% during the first quarter. SMART Wealth LLC now owns 366 shares of the company's stock worth $317,000 after purchasing an additional 12 shares in the last quarter. Hedge funds and other institutional investors own 85.07% of the company's stock.

Analyst Ratings Changes

MCK has been the subject of a number of recent analyst reports. Barclays raised their price objective on shares of McKesson from $925.00 to $1,000.00 and gave the company an "overweight" rating in a research report on Wednesday, August 19th. Citigroup boosted their target price on McKesson from $945.00 to $1,000.00 and gave the stock a "buy" rating in a research report on Friday, July 24th. Wall Street Zen upgraded McKesson from a "hold" rating to a "buy" rating in a research report on Saturday, October 17th. UBS Group increased their target price on McKesson from $1,080.00 to $1,200.00 and gave the stock a "buy" rating in a research note on Friday, October 16th. Finally, Royal Bank Of Canada reissued a "sector perform" rating and issued a $845.00 price target on shares of McKesson in a report on Monday, September 14th. Fifteen analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the company's stock. According to MarketBeat, McKesson currently has an average rating of "Moderate Buy" and an average target price of $997.12.

McKesson Stock Performance

Shares of NYSE MCK opened at $1,014.79 on Thursday. The firm has a market capitalization of $118.31 billion, a P/E ratio of 27.16, a PEG ratio of 2.05 and a beta of 0.30. McKesson Corporation has a one year low of $723.68 and a one year high of $1,030.27. The company's fifty day moving average is $905.65 and its two-hundred day moving average is $840.38.

McKesson (NYSE:MCK - Get Free Report) last posted its quarterly earnings results on Wednesday, August 5th. The company reported $9.93 earnings per share for the quarter, topping analysts' consensus estimates of $9.56 by $0.37. The business had revenue of $105.38 billion for the quarter, compared to analysts' expectations of $103.88 billion. McKesson had a net margin of 1.12% and a negative return on equity of 253.21%. The business's revenue for the quarter was up 7.7% on a year-over-year basis. During the same period in the prior year, the company posted $8.26 EPS. McKesson has set its FY 2027 guidance at 44.200-45.000 EPS. On average, sell-side analysts forecast that McKesson Corporation will post 44.71 earnings per share for the current fiscal year.

McKesson Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Monday, January 4th. Investors of record on Tuesday, December 1st will be issued a dividend of $0.94 per share. The ex-dividend date of this dividend is Tuesday, December 1st. This represents a $3.76 dividend on an annualized basis and a yield of 0.4%. McKesson's payout ratio is currently 10.06%.

Key Stories Impacting McKesson

Here are the key news stories impacting McKesson this week:

• Positive Sentiment: Analyst price-target increases supported the long-term outlook. UBS raised its target to $1,200, while Mizuho lifted its target to $1,020 from $905, although Mizuho maintained a neutral rating. The analyst actions followed McKesson’s recent strength and helped the stock reach a new one-year high. UBS raises target for McKesson
• Positive Sentiment: McKesson declared its regular quarterly dividend. The company will pay $0.94 per share on January 4, 2027, to shareholders of record on December 1. The dividend provides continuity for income-focused investors, though the annualized yield is modest at approximately 0.4%. McKesson declares quarterly dividend
• Neutral Sentiment: Investor attention remains elevated. McKesson was among the more-trending stocks on Zacks, but the article primarily reviews existing fundamentals rather than introducing a new catalyst. Its latest reported quarter showed earnings and revenue above estimates, with revenue up 7.7% year over year and fiscal 2027 EPS guidance of $44.20–$45.00. Is Trending Stock McKesson a Buy Now?
• Negative Sentiment: An executive sale may have added modest selling pressure. EVP Francisco Fraga sold 800 shares worth approximately $796,640. However, the transaction was conducted under a pre-arranged Rule 10b5-1 trading plan, reducing its significance as a discretionary bearish signal. McKesson executive stock sale

Insiders Place Their Bets

In other McKesson news, CAO Napoleon B. Rutledge, Jr. sold 111 shares of the stock in a transaction dated Tuesday, September 8th. The shares were sold at an average price of $891.45, for a total value of $98,950.95. Following the completion of the transaction, the chief accounting officer directly owned 521 shares of the company's stock, valued at approximately $464,445.45. This trade represents a 17.56% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Bradley E. Lerman sold 301 shares of the stock in a transaction dated Monday, August 10th. The shares were sold at an average price of $892.33, for a total transaction of $268,591.33. Additional details regarding this sale are available in the official SEC disclosure. Over the last three months, insiders have sold 1,212 shares of company stock worth $1,164,182. 0.06% of the stock is owned by company insiders.

McKesson Company Profile

McKesson Corporation is a healthcare services and information technology company that distributes pharmaceuticals and medical products to pharmacies, hospitals, health systems, physicians and other healthcare providers. The company also provides technology, data and business solutions designed to support prescription management, pharmacy operations and patient care.

McKesson's principal activities include pharmaceutical distribution, medical-surgical supply distribution, specialty pharmaceutical services and oncology care support.

Want to see what other hedge funds are holding MCK? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for McKesson Corporation (NYSE:MCK - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.